Lifestyle strongly influences many elements of health. Regular physical activity, smoking cessation, and appropriate intake of energy, fluids, and macro- and micronutrients can prevent many chronic conditions, improve function, and increase quality of life. However, over time, a positive energy balance due to sedentary lifestyle and excess energy intake leads to obesity, especially increased visceral fat deposits. Visceral obesity, which is prevalent in the elderly, is an important risk factor for hypertension, type 2 diabetes, and dyslipidaemia. In turn, obesity and its complications are risk factors for nephropathy and chronic kidney disease (CKD).
The human life span is also associated with long-term exposure to environmental and behavioural factors. Thus, the effects of adverse behaviors on health increase with aging. Although many lifestyle-related risk factors are modifiable, changing behaviors can be difficult. Moreover, little evidence exists to show that lifestyle modification decreases the risk for CKD and improves kidney outcomes. It is particularly difficult to demonstrate the effect of modifying lifestyle-related risk factors on renal function, because some damage (e.g., endothelial dysfunction and arteriosclerosis) is irreversible.
This review summarizes the current knowledge concerning the effects of lifestyle and its modification on the occurrence and progression of CKD, focusing on the elderly population.
The recently completed PolSenior study analyzed fluid intake in an elderly Polish population (1). The results showed that inadequate fluid intake (< 1000 ml/day) is more common with increasing age (13.3% at 65-69 years vs. 26.5% at > 90 years) and more common among women than men (25.3% vs. 19.4%). Inadequate fluid intake can reduce the glomerular filtration rate (GFR), which may partially explain the greater prevalence of low estimated GFR (eGFR) (< 60 ml/min/1.73 m2) among women (2). The results of the PolSenior study revealed that 96.8% of elderly subjects who met the criteria for CKD were unaware they had the disease (2).
In daily clinical practice, physicians recommend generous fluid intake (≥ 4 l/day) for patients with CKD, with higher fluid intake for patients with higher serum creatinine levels. However, direct evidence for the association between adequate fluid intake and better kidney performance is lacking (3). Indirect evidence for this recommendation includes the results of two cross-sectional studies performed in different populations. These studies showed that increasing fluid intake was associated with a lower risk of CKD (defined as eGFR < 50 ml/min). Participants with the highest quintile of fluid intake (3.2 l/day) had the lowest risk (odds ratio [OR] = 0.50, 95% confidence interval [CI] 0.32-0.77) (4).
Better documented is the effect of dehydration on kidney function. Dehydration is an important risk factor for acute kidney injury. Adequate fluid intake may be even more important for individuals with undiagnosed CDK.
Although there is no evidence that alcohol consumption impairs renal function, heavy drinkers may experience repeated episodes of acute kidney injury caused by dehydration (5). These episodes may induce or exacerbate interstitial kidney fibrosis. Studies analysing the relationship between moderate or heavy drinking and CKD have reported conflicting results. Several studies found that moderate alcohol consumption was not associated with renal dysfunction (6, 7). For example, a 14-year prospective study of 11 023 initially healthy men showed that those who consumed two to six drinks per week had a risk for serum creatinine elevation (> 133 μmol/L) similar to that of men who consumed no more than one drink per week (6). Similarly, results of the Australian Diabetes, Obesity, and Lifestyle (AusDiab) study (8) showed that moderate drinking decreased the risk of de novo development of renal function impairment (eGFR < 60 ml/min/1.73 m2) in both men (OR = 0.34, 95% CI 0.22-0.59) and women (OR = 0.68, 95% CI 0.36-1.27). Funakoshi et al. recently reported that the prevalence of CKD is 40% lower in daily drinkers than in non-drinkers among professionally active men (9). In addition, Schaeffner et al. (6) found that consuming at least seven drinks per week had a beneficial effect on kidney function (OR = 0.71, 95% CI 0.55-0.92). In contrast, Shankar et al. reported that frequent alcohol consumption (> four drinks per week) increased the risk for CKD (OR = 1.99, 95% CI 0.99-4.01) in 5-year longitudinal analysis of 3.392 Americans without CKD (10). Additionally, Perneger et al. reported a higher prevalence of drinkers among patients with end-stage kidney disease than in age-matched controls (11).
The above-mentioned studies did not all focus on the elderly; however, results obtained in younger populations should be generalizable to the elderly population. Results of the PolSenior study show that 17.1% of the elderly Polish participants (men 27.0%, women 6.9%) reported frequent or very frequent alcohol consumption (12). Frequent alcohol consumption is associated with a lower risk for impaired kidney function (eGFR < 60 ml/min/1.73 m2) in the elderly Polish population (22.4% vs. 36.5% of those who abstained from drinking) (13).
Smoking is another known risk factor for CKD. A number of pathophysiological links between smoking and kidney damage have been identified, including the promotion of renal atherosclerosis (14), alterations in systemic and renal hemodynamics (15), and endothelial dysfunction (16). The relationship between smoking and end-stage kidney disease was initially shown in a longitudinal study of diabetic patients (17). A study by Biesenbach et al. reported that the rate of GFR loss was twice as high in smokers as in non-smokers (18).
The National Health and Nutrition Examination Survey II (NHANES II) reported that individuals who smoked > 20 cigarettes/day had a 2.3-times higher risk for CKD (7). In the AusDiab study, smoking was significantly associated with renal impairment in men (OR = 3.59) but not in women (19). In this study, lifetime exposure, but not current level of smoking, was related to lower eGFR (19).
Smokers may also have an increased risk of albuminuria. In the general Korean population, smoking was associated with a 38% higher risk for albuminuria (as assessed by urine dipstick) (20). Pinto-Sietsma et al. observed a 65% higher risk of low-grade albuminuria in smokers (21). Some studies have suggested that men are more vulnerable to develop albuminuria than women (22, 23). Haroun et al. estimated the risk of CKD attributable to cigarette smoking in a population-based study as 31% (24). However, CKD risk related to smoking in the elderly population should be greater, because of long-term exposure to smoke along with other factors that lead to kidney injury.
There is no doubt that smoking cessation improves overall health. Smoking cessation may also specifically benefit the kidneys. For example, the rate of GFR loss among former smokers is lower than that of current smokers (25). Moreover, eGFR decline is more rapid among current smokers (-1.79 ± 0.35 ml/min/y) compared with former smokers (-1.54 ± 0.37 ml/min/y) (26). However, it has not yet been demonstrated that smoking cessation significantly improves kidney performance in elderly populations.
NHANES III reported that, compared with elderly individuals without CKD, those with CKD were more likely to be physical inactive (28.0% vs. 13.5%) and disabled (23.9% vs. 17.6%), defined as having difficulty with performing the activities of daily living (27, 28). However, the cross-sectional study design precluded the establishment of causality. Similar findings were obtained in a study carried out in the United Kingdom, where low eGFR (< 45 ml/min/1.73 m2) was associated with impaired functional status (i.e., partial dependence on activities of daily living and lack of physical activity) in the elderly population (29). The effect of physical inactivity on mortality was similar between groups (CKD and non-CKD) (27).
1. Kołłajtis-Dołowy A, Pietruszewska B, Olszanecka-Glinianowicz M et al.: Zwyczaje żywieniowe osób w wieku podeszłym. [W:] Mossakowska M, Więcek A, Błędowski P (red.): Aspekty medyczne, psychologiczne, socjologiczne i ekonomiczne starzenia ludzi w Polsce. Poznań, Termedia 2012; p. 359-378.
2. Chudek J, Wieczorowska-Tobis K, Zejda J et al.: Częstość występowania przewlekłej choroby nerek w populacji u osób w wieku podeszłym w Polsce. [W:] Mossakowska M, Więcek A, Błędowski P (red.): Aspekty medyczne, psychologiczne, socjologiczne I ekonomiczne starzenia ludzi w Polsce. Poznań, Termedia 2012; p. 223-236.
3. Wenzel UO, Hebert LA, Stahl RA et al.: My doctor said I should drink a lot! recommendations for fluid intake in patients with chronic kidney disease. Clin J Am Soc Nephrol 2006; 1: 344-346.
4. Strippoli GF, Craig JC, Rochtchina E et al.: Fluid and nutrient intake and risk of chronic kidney disease. Nephrology (Carlton) 2011; 16: 326-334.
5. Robertson C, Paton JY: Acute renal failure after a beer-drinking binge. Br Med J 1980; 280: 938-939.
6. Schaeffner ES, Kurth T, de Jong PE et al.: Alcohol consumption and the risk of renal dysfunction in apparently health men. Arch Intern Med 2005; 165: 1048-1053.
7. Stengel B, Tarver-Carr ME, Powe NR et al.: Lifestyle factors, obesity and the risk of chronic kidney disease. Epidemiology 2003; 14: 479-487.
8. White SL, Polkinghorne KR, Cass A et al.: Alcohol consumption and 5-year onset of chronic kidney disease: the AusDiab study. Nephrol Dial Transplant 2009; 24: 2464-2472.
9. Funakoshi Y, Omori H, Onoue A et al.: Association between frequency of drinking alcohol and chronic kidney disease in men. Environ Health Prev Med 2012; 17: 199-204.
10. Shankar A, Klein R, Klein BE: The association among smoking, heavy drinking, and chronic kidney disease. Am J Epidemiol 2006; 164: 263-271.
11. Perneger TV, Whelton PK, Puddey IB et al.: Risk of endstage renal disease associated with alcohol consumption. Am J Epidemiol 1999; 150: 1275-1281.
12. Hartleb M, Gutkowski K, Chudek J et al.: Częstość występowania chorób wątroby u osób w wieku podeszłym w Polsce. [W:] Mossakowska M, Więcek A, Błędowski P (red.): Aspekty medyczne, psychologiczne, socjologiczne i ekonomiczne starzenia ludzi w Polsce. Poznań, Termedia 2012; p. 205-222.
13. Chudek J, Wieczorowska-Tobis K, Zejda J et al.: The prevalence of chronic kidney disease and its relation to socio-economic conditions in the Polish elderly population. Nephrol Dial Transplant [inpress].
14. Nicholson JP, Teichman SL, Alderman MH et al.: Cigarette smoking and renovascular hypertension. Lancet 1983; 2: 765-766.
15. Ritz E, Benck U, Franek E et al.: Effects of smoking on renal hemodynamics in healthy volunteers and in patients with glomerular disease. J Am Soc Nephrol 1998; 9: 1798-1804.
16. Blann AD, McCollum CN: Adverse influence of cigarette smoking on the endothelium. Thromb Haemost 1993; 70: 707-711.
17. Brancati FL, Whelton PK, Randall BL et al.: Risk of end-stage renal disease in diabetes mellitus: a prospective cohort study of men screened for MRFIT. Multiple Risk Factor Intervention Trial. JAMA 1997; 278: 2069-2074.
18. Biesenbach G, Grafinger P, Janko O et al.: Influence of cigarette-smoking on the progression of clinical diabetic nephropathy in type 2 diabetic patients. Clin Nephrol 1997; 48: 146-150.
19. Briganti EM, Branley P, Chadban SJ et al.: Smoking is associated with renal impairment and proteinuria in the normal population: the AusDiab kidney study. Australian Diabetes, Obesity and Lifestyle Study. Am J Kidney Dis 2002; 40: 704-712.
20. Yoon HJ, Park M, Yoon H et al.: The differential effect of cigarette smoking on glomerular filtration rate and proteinuria in an apparently healthy population. Hypertens Res 2009; 32: 214-219.
21. Pinto-Sietsma SJ, Janssen WM, Hillege HL, et al.: Urinary albumin excretion is associated with renal functional abnormalities in a nondiabetic population. J Am Soc Nephrol 2000; 11: 1882-1888.
22. Tozawa M, Iseki K, Iseki C et al.: Influence of smoking and obesity on the development of proteinuria. Kidney Int 2002; 62: 956-962.
23. Halimi JM, Giraudeau B, Vol S et al.: The risk of hypertension in men: direct and indirect effects of chronic smoking. J Hypertens 2002; 20: 187-193.
24. Haroun MK, Jaar BG, Hoffman SC et al.: Risk factors for chronic kidney disease: A prospective study of 23 534 men and women in Washington County, Maryland. J Am Soc Nephrol 2003; 14: 2934-2941.
25. Sawicki PT, Didjurgeit U, Muhlhauser I et al.: Smoking is associated with progression of diabetic nephropathy. Diabetes Care 1994; 17: 126-131.
26. Phisitkul K, Hegazy K, Chuahirun T et al.: Continued smoking exacerbates but cessation ameliorates progression of early type 2 diabetic nephropathy. Am J Med Sci 2008; 335: 284-291.
27. Beddhu S, Baird BC, Zitterkoph J et al.: Physical activity and mortality in chronic kidney disease (NHANES III). Clin J Am SocNephrol 2009; 4: 1901-1906.
28. Plantinga LC, Johansen K, Crews DC et al.: Association of CKD with disability in the United States. Am J Kidney Dis 2011; 57: 212-227.
29. Roderick PJ, Atkins RJ, Smeeth L et al.: Detecting chronic kidney disease in older people; what are the implications? Age Ageing 2008; 37: 179-186.
30. White SL, Dunstan DW, Polkinghorne KR et al.: Physical inactivity and chronic kidney disease in Australian adults: the AusDiab study. Nutr Metab Cardiovasc Dis 2011; 21: 104-112.
31. Heiwe S, Jacobson SH: Exercise training for adults with chronic kidney disease. Cochrane Database Syst Rev 2011; 10: CD003236.
32. Olszanecka-Glinianowicz M, Chudek J, Kołłajtis-Dołowy A et al.: Stan odżywienia u osób w wieku podeszłym. [W:] Mossakowska M, Więcek A, Błędowski P (red.): Aspekty medyczne, psychologiczne, socjologiczne i ekonomiczne starzenia ludzi w Polsce. Poznań, Termedia 2012; p. 335-358.
33. Rea DJ, Heinbach JK, Grande JP et al.: Glomerular volume and renal histology in obese and non-obese living kidney donors. Kidney Int 2006; 70: 1636-1641.
34. Chagnac A, Weinstein T, Korzets A et al.: Glomerular hemodynamic in severe obesity. Am J Physiol Renal Physiol 2000; 278: F817-822.
35. Esler M, Rumanti M, Weisner G: Sympathetic nervous system and insulin resistance: from obesity to diabetes. Am J Hypertens 2001; 14 (Suppl 1): 304s-309s.
36. DeJong PE, Verhave JC, Pinto-Sietsma SJ et al.: Obesity and target organ damage: the kidney. Int J Obesity 2002; 26 (Suppl. 4): S21-24.
37. Toto RD, Greene T, Hebert LA: Relationship of body mass index and proteinuria in hypertensive nephrosclerosis: results from the African American Study of Kidney Disease and Hypertension (AASK) cohort. Am J Kidney Dis 2010; 56: 896-906.
38. Kohler KA, McClellan WM, Ziemer DC et al.: Risk factors for microalbuminuria in black Americans with newly diagnosed type 2 diabetes. Am J Kidney Dis 2000; 36: 903-913.
39. Morales E, Valero MA, León M et al.: Beneficial effects of weight loss in overweight patients with chronic proteinuric nephropathies. Am J Kidney Dis 2003; 41: 319-327.
40. Ritz E, Koleganova N, Piecha G: Is there an obesity-metabolic related glomerulopathy? Curr Opin Nephrol Hypert 2011; 20: 44-49.
41. Kamlan N, Markowitz GS, Valeri AM: Obesity-related glomerulopathy: an emerging epidemic. Kidney Int 2001; 51: 1498-1509.
42. Fox CS, Larson MG, Leip EP et al.: Prediction of new-onset kidney disease in a community-based population. JAMA 2004; 291: 844-850.
43. Iseki K, Ikenuya Y, Kinjo K: Body mass index and the risk of development of end-stage renal disease in a screened cohort. Kidney Int 2004; 65: 1870-1879.
44. Hsu C, McCulloch CE, Iribarren C et al.: Body mass index and risk for end-stage renal disease. Ann Intern Med 2006; 144: 21-28.
45. Sjerblad E, Fored CM, Lindbald P: Obesity and risk for chronic renal failure. J Am Soc Nephrol 2006; 17: 1695-1702.
46. O’Donnell MP, Kasiske BL, Schmitz PG et al.: High protein intake accelerates glomerulosclerosis independent of effects on glomerular hemodynamics. Kidney Int 1990; 37: 1263-1269.
47. Hostetter TH, Meyer TW, Rennke HG et al.: Chronic effects of dietary protein in the rat with intact and reduced renal mass. Kidney Int 1986; 30: 509-517.
48. Tuttle KR, Bruton JL: Effect of insulin therapy on renal hemodynamic response to amino acids and renal hypertrophy in non-insulin-dependent diabetes. KidneyInt 1992; 42: 167-173.
49. Goldberg T, Cai W, Peppa M et al.: Advanced glycoxidation end products in commonly consumed foods. J Am Diet Assoc 2004; 104: 1287-1291.
50. Uribarri J, Tuttle KR: Advanced glycation end products and nephrotoxicity of high protein diets. Clin J Am SocNephrol 2006; 1: 1293-1299.
51. Uribarri J, Peppa M, Cai W et al.: Restriction of dietary glycotoxins reduces excessive advanced glycation end products in renal failure patients. J Am SocNephrol 2003; 14: 728-731.
52. Tanji N, Markowitz GS, Fu C et al.: Expression of advanced glycationend products and their cellular receptor RAGE indiabetic nephropathy and nondiabetic renal disease. J Am Soc Nephrol 2000; 11: 1656-1666.
53. Wrone EM, Carnethon MR, Palaniappan L et al.: Association of dietary protein intake and microalbuminuriain healthy adults: Third National Health and Nutrition Examination Survey. Am J Kidney Dis 2003; 41: 580-587.
54. Knight EL, Stampfer MJ, Hankinson SE et al.: The impact of protein intake on renal function decline in women with normal renal function or mild renal insufficiency. Ann Intern Med 2003; 138: 460-467.
55. Hoogeveen EK, Kostense PJ, Jager A et al.: Serum homocysteine level and protein intake are related to risk of microalbuminuria: the Hoorn Study. Kidney Int 1998; 54: 203-209.
56. Bernstein AM, Treyzon L, Zhaoping L: Are high-protein diet, vegetable-based diets safe for kidney function? A review of the literature. J Am Diet Assoc 2007; 17: 644-650.
57. Pedrini MT, Levey AS, Lau J et al.: The effect of dietary protein restriction on the progression of diabetic and nondiabetic renal diseases: a meta-analysis. Ann Intern Med 1996; 124: 627-632.
58. Fouque D, Laville M, Boissel JP et al.: Controlled low protein diets in chronic renal insufficiency: meta-analysis. BMJ 1992; 304: 216-220.
59. Pan Y, Guo LL, Hui MJ: Low-protein diet for diabetic nephropathy: a meta-analysis of randomized controlled trials. Am J ClinNutr 2008; 88: 660-666.
60. Levey AS, Greene T, Beck GJ et al.: Dietary protein restriction and the progression of chronic renal disease: what have all of the results of the MDRD study shown? Modification of diet in renal disease study group. J Am Soc Nephrol 1999; 10: 2426-2439.
61. Brunori G, Viola BF, Parrinelo G et al.: Efficacy and safety of a very-low-protein diet when postponing dialysis in elderly: a prospective randomized multicenter controlled study. Am J Kidney Dis 2007; 49: 569-580.
62. Wolfe RR, Miller SL, Miller KB: Optimal protein intake in the elderly. Clin Nutr 2008; 27: 675-684.
63. Eilat-Adar S, Xu J, Zephier E, O’Leary V et al.: Adherence to dietary recommendations for saturated fat, fiber, and sodium is low in American Indians and other U.S. adults with diabetes. J Nutr 2008; 138: 1699-1704.
64. Lau K: Phosphate excess and progressive renal failure: the precipitation-calcification hypothesis. Kidney Int1989; 36: 918-937.
65. Voormolen N, Noordzij M, Grootendorst DC et al.: High plasma phosmortality in pre-dialysis patients. Nephrol Dial Transplant 2007; 22: 2909-2916.
66. Sigrist MK, Chiarelli G, Lim L et al.: Early initiation of phosphate lowering dietary therapy in non-dialysis chronic kidney disease: a critical review. J Ren Care 2009; 35: 71-78.
67. Murtaugh MA, Filipowicz R, Baird BC et al.: Dietary phosphorus intake and mortality in moderate chronic kidney disease: NHANES III. Nephrol Dial Transplant 2012; 27: 990-996.
68. American Diabetes Association. ADA standards of medical care in diabetes – 2008. Diabetes Care 2008; 31: 20-21.
69. Bantle JP: Dietary fructose and metabolic syndrome and diabetes. J Nutr 2009; 139: 1263-1268.
70. American Heart Association. Step I, step II, and TLC diets.Available from: http://www.americanheart.org/presenter jhtml?identifier_4764. 2008.
71. Mollsten A, Dahlquist G, Stattin EL et al.: Higher intakes of fish protein are related to a lower risk of microalbuminuria in young Swedish type 1 diabetic patients. Diabetes Care 2001; 24: 805-811.
72. Huskey J, Lindenfeld J, Cook T et al.: Effect of simvastatin on kidney function loss in patients with coronary heart disease: findings from the Scandinavian Simvastatin Survival Study (4S). Atherosclerosis 2009; 205: 202-206.
73. Choudhury D, Tuncel M, Levi M: Disorders of lipid metabolism and chronic kidney disease in the elderly. SeminNephrol 2009; 29: 610-620.
74. Donfrancesco C, Ippolito R, Lo Noce C et al.: Excess dietary sodium and inadequate potassium intake in Italy: Results of the MINISAL study. Nutr Metab Cardiovasc Dis 2012 [Epub ahead of print].
75. Kreutz R, Fernandez-Alfonso MS, Liu Y et al.: Induction of cardiac angiotensin I-converting enzyme with dietary NaCl-loading in genetically hypertensive and normotensive rats. J Mol Med 1995; 73: 243-248.
76. Dworkin LD, Benstein JA, Tolbert E et al.: Salt restriction inhibits renal growth and stabilizes injury in rats with established renal disease. J Am Soc Nephrol 1996; 7: 437-442.
77. Kuriyama S, Tomonari H, Ohtsuka Y et al.: [Salt intake and the progression of chronic renal diseases]. Nippon JinzoGakkai Shi 2003; 45: 751-758.
78. Vegter S, Perna A, Postma MJ et al.: Sodium intake, ACE inhibition, and progression to ESDR. J Am Soc Nephrol 2012; 23: 165-173.